These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9224084)

  • 1. Ocular damage associated with proton pump inhibitors.
    Schönhöfer PS; Werner B; Tröger U
    BMJ; 1997 Jun; 314(7097):1805. PubMed ID: 9224084
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole (correction of omepraxole) and ocular damage. Facts of cases are unclear.
    Riordan-Eva P; Sanders MD
    BMJ; 1998 Jan; 316(7124):67; author reply 68. PubMed ID: 9451275
    [No Abstract]   [Full Text] [Related]  

  • 3. Omeprazole (correction of omepraxole) and ocular damage. Lack of causality holds true.
    Sachs G
    BMJ; 1998 Jan; 316(7124):67-8. PubMed ID: 9451277
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole (correction of omepraxole) and ocular damage. Concerns on safety of drug are unwarranted.
    Lessell S
    BMJ; 1998 Jan; 316(7124):67; author reply 68. PubMed ID: 9451276
    [No Abstract]   [Full Text] [Related]  

  • 5. [Two cases of ocular damage associated with proton pump inhibitors].
    Kohno M; Yamada M; Okumura T; Hori K; Hoshino U; Yoshimura T
    Nihon Shokakibyo Gakkai Zasshi; 2000 May; 97(5):575-9. PubMed ID: 10846412
    [No Abstract]   [Full Text] [Related]  

  • 6. [Photodistributed cutaneous drug reaction induced by proton pump inhibitors].
    Raison-Peyron N; Minh HB; Peyron JL; Demoly P; Guillot B
    Therapie; 2005; 60(1):85-7. PubMed ID: 15929479
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.
    Epstein M; McGrath S; Law F
    N Engl J Med; 2006 Oct; 355(17):1834-6. PubMed ID: 17065651
    [No Abstract]   [Full Text] [Related]  

  • 8. Proton pump inhibitors.
    Scully C
    Br Dent J; 2010 Feb; 208(4):147. PubMed ID: 20186183
    [No Abstract]   [Full Text] [Related]  

  • 9. Omeprazole in oesophageal reflux disease.
    Dawson R; Manson JM
    Lancet; 2000 Nov; 356(9243):1770-1. PubMed ID: 11095286
    [No Abstract]   [Full Text] [Related]  

  • 10. Omeprazole and excessive sweating, if unrecognised, may lead to unnecessary investigations.
    Mamun M; Caddick S; Siddiqi MA
    Postgrad Med J; 1999 Nov; 75(889):701-2. PubMed ID: 10621892
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute kidney injury following proton pump inhibitor therapy.
    Brewster UC; Perazella MA
    Kidney Int; 2007 Mar; 71(6):589-93. PubMed ID: 17164832
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton pump inhibitors and iron deficiency: is the connection real?
    Nand S; Tanvetyanon T
    South Med J; 2004 Sep; 97(9):799. PubMed ID: 15455957
    [No Abstract]   [Full Text] [Related]  

  • 13. [Safety of proton pump inhibitors for long-term application].
    Kuipers E
    Eksp Klin Gastroenterol; 2006; (4):48-52. PubMed ID: 17269424
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term use of proton pump inhibitors: are they really safe? A case of delayed acute interstitial nephritis.
    Krishnamurthy M; Snyder R; Bachurina M
    J Am Geriatr Soc; 2009 Aug; 57(8):1513-4. PubMed ID: 19682153
    [No Abstract]   [Full Text] [Related]  

  • 15. A cohort study of the ocular safety of anti-ulcer drugs.
    García Rodríguez LA; Mannino S; Wallander MA; Lindblom B
    Br J Clin Pharmacol; 1996 Aug; 42(2):213-6. PubMed ID: 8864320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole-associated rhabdomyolysis.
    Tanaka K; Nakada TA; Abe R; Itoga S; Nomura F; Oda S
    Crit Care; 2014 Jul; 18(4):462. PubMed ID: 25184508
    [No Abstract]   [Full Text] [Related]  

  • 17. Asymptomatic giardiasis--an association with proton pump inhibitors?
    Mukherjee S
    Am J Gastroenterol; 2000 Dec; 95(12):3666-7. PubMed ID: 11151928
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical inquiries. Is the long-term use of proton pump inhibitors safe?
    Malaty W; Stigleman S; Mayer J; Guthmann RA
    J Fam Pract; 2004 Sep; 53(9):740-2. PubMed ID: 15353165
    [No Abstract]   [Full Text] [Related]  

  • 19. Proton pump inhibitor-induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus.
    Hung R; Sangle SR; Benton E; D'Cruz DP; McGibbon D
    Clin Exp Dermatol; 2015 Oct; 40(7):808-9. PubMed ID: 25809120
    [No Abstract]   [Full Text] [Related]  

  • 20. Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy.
    Park M; Liu GT; Piltz-Seymour J; Wisda CL; Rook AH; Junkins-Hopkins JM; Nasta SD; Kim EJ
    Leuk Lymphoma; 2007 Apr; 48(4):808-11. PubMed ID: 17454642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.